SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-158322
Filing Date
2021-05-12
Accepted
2021-05-12 07:14:58
Documents
3
Period of Report
2021-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d130604d8k.htm 8-K 17795
2 EX-99.1 d130604dex991.htm EX-99.1 46392
3 GRAPHIC g130604dsp4.jpg GRAPHIC 3420
  Complete submission text file 0001193125-21-158322.txt   70388
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 21913435
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences